Amgen’s Rebate Bundling Makes It ‘Economically Unfeasible’ For Regeneron To Sell Praluent

 
• By Brenda Sandburg
  
Rebate
Regeneron claims Amgen's rebate bundling is restricting access to Praluent • Source: Shutterstock

More from Legal & IP

More from Pink Sheet